| 000 | 01884 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517025017.0 | ||
| 264 | 0 | _c20160418 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0124000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDas, Laxmidhar | |
| 245 | 0 | 0 |
_aLong term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer. _h[electronic resource] |
| 260 |
_bPloS one _c2015 |
||
| 300 |
_ae0124000 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 | _aConsensus Sequence |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 |
_aGlutathione Reductase _xgenetics |
| 650 | 0 | 4 |
_aGlutathione Transferase _xgenetics |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLymphoma, T-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred AKR |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xgenetics |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xgenetics |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xgenetics |
| 650 | 0 | 4 |
_aTumor Microenvironment _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aVinayak, Manjula | |
| 773 | 0 |
_tPloS one _gvol. 10 _gno. 4 _gp. e0124000 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0124000 _zAvailable from publisher's website |
| 999 |
_c24791979 _d24791979 |
||